Patent Assignment
Reel/Frame 040937/0147
Change of Name
Recorded: 2017-01-10
Pages: 8
Assignor
HYPERION THERAPEUTICS, INC.
Executed: 2015-05-07
Assignee
HORIZON THERAPEUTICS, INC.
2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CALIFORNIA, 94005
Covered Property
(1)
Methods of Therapeutic Monitoring of Phenylacetic Acid Prodrugs
Application:
15/402,780 →
Publication:
US 2017/0266143
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 10, 2017
From: SCHARSCHMIDT, BRUCE; MOKHTARANI, MASOUD
To: HYPERION THERAPEUTICS, INC.
Reel/Frame 040936/0904 →
Certificate of Conversion
Jan 10, 2017
From: HORIZON THERAPEUTICS, INC.
To: HORIZON THERAPEUTICS, LLC
Reel/Frame 041324/0824 →
Security Agreement
Oct 24, 2018
From: HORIZON PHARMA RHEUMATOLOGY LLC; HZNP LIMITED; HORIZON THERAPEUTICS, LLC
To: CITIBANK, N.A.
Reel/Frame 047720/0068 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.); HZNP LIMITED; HORIZON THERAPEUTICS U.S. HOLDING LLC (SUCCESSOR IN INTEREST TO HORIZON THERAPEUTICS, LLC)
Reel/Frame 065154/0075 →